Oxford Nanopore Technologies plc (ONTTF)
USD 1.8
(-7.69%)
USD 1.8
(-7.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 90.48 Million GBP | -26.92% |
| 2022 | 123.81 Million GBP | 69.15% |
| 2021 | 73.19 Million GBP | 56.14% |
| 2020 | 46.87 Million GBP | 82.99% |
| 2019 | 25.61 Million GBP | 59.97% |
| 2018 | 16.01 Million GBP | 138.11% |
| 2017 | 6.72 Million GBP | 942.79% |
| 2016 | 645 Thousand GBP | 254.4% |
| 2015 | 182 Thousand GBP | 0.0% |
| 2014 | - GBP | 0.0% |
| 2013 | - GBP | -100.0% |
| 2012 | 149.49 Thousand GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 49.46 Million GBP | 0.0% |
| 2023 Q2 | 49.54 Million GBP | 100.0% |
| 2023 Q3 | 20.46 Million GBP | -58.69% |
| 2023 Q4 | 40.93 Million GBP | 100.0% |
| 2023 FY | 90.48 Million GBP | -26.92% |
| 2023 Q1 | 24.77 Million GBP | -45.98% |
| 2022 Q4 | 45.85 Million GBP | 100.0% |
| 2022 Q1 | 38.97 Million GBP | -9.34% |
| 2022 Q2 | 77.95 Million GBP | 100.0% |
| 2022 Q3 | 22.92 Million GBP | -70.59% |
| 2022 FY | 123.81 Million GBP | 69.15% |
| 2021 Q1 | 15.1 Million GBP | -50.95% |
| 2021 FY | 73.19 Million GBP | 56.14% |
| 2021 Q4 | 42.99 Million GBP | 100.0% |
| 2021 Q2 | 30.2 Million GBP | 100.0% |
| 2021 Q3 | 21.49 Million GBP | -28.83% |
| 2020 Q4 | 30.78 Million GBP | 100.0% |
| 2020 Q1 | 8.04 Million GBP | 0.0% |
| 2020 Q2 | 16.09 Million GBP | 100.0% |
| 2020 Q3 | 15.39 Million GBP | -4.35% |
| 2020 FY | 46.87 Million GBP | 82.99% |
| 2019 FY | 25.61 Million GBP | 59.97% |
| 2018 FY | 16.01 Million GBP | 138.11% |
| 2017 FY | 6.72 Million GBP | 942.79% |
| 2016 FY | 645 Thousand GBP | 254.4% |
| 2015 FY | 182 Thousand GBP | 0.0% |
| 2014 FY | - GBP | 0.0% |
| 2013 FY | - GBP | -100.0% |
| 2012 FY | 149.49 Thousand GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -503.247% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -2916760.09% |
| SQZ Biotechnologies Company | 9.79 Million USD | -823.841% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -672.945% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 24.034% |
| Mesoblast Limited | -35.16 Million USD | 357.282% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 265051.684% |
| Genus plc | 178.7 Million USD | 49.367% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -21959.659% |
| Marizyme, Inc. | 457.7 Thousand USD | -19668.539% |
| ContraFect Corporation | -154 Thousand USD | 58853.896% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 822654.545% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 181062.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -117773.66% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -137559.749% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 23449.875% |
| MultiCell Technologies, Inc. | 49.32 USD | -183456915.41% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -124.714% |
| EV Biologics, Inc. | 48.9 Thousand USD | -184932.72% |
| Q BioMed Inc. | -8988.00 USD | 1006786.693% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -220.23% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 586724.741% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 58.892% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -129158.571% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 72921.144% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -145307.065% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 1827260.743% |
| Arch Therapeutics, Inc. | -2439.00 USD | 3709858.098% |
| IMV Inc. | -962.29 Thousand USD | 9502.597% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -64299.288% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 92886.751% |
| GB Sciences, Inc. | -624.00 USD | 14500260.256% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 105276.222% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 98.803% |
| Halberd Corporation | -208.00 USD | 43500580.769% |
| Enzolytics Inc. | 30.7 Thousand USD | -294549.603% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -6567.02% |
| SYBLEU INC | 11.69 Thousand USD | -773506.361% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -18655.143% |
| argenx SE | 1.1 Billion USD | 91.837% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 450.729% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -14555.547% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 77.907% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 1021791.509% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -103.98% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 8026.0% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -9058.172% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -841.432% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 108009.456% |
| BioStem Technologies, Inc. | 15.42 Million USD | -486.593% |
| ONE Bio Corp. | 20.12 Million USD | -349.585% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 764620.49% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 187590.416% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -51146.602% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -51146.602% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 17685.858% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 14458.918% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 312103.448% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -20004.968% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 28418.941% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -1863.563% |
| Bioxytran, Inc. | -8285.00 USD | 1092206.216% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 24357.641% |
| Neutra Corp. | 14.33 Thousand USD | -631089.397% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 110442.683% |
| PureTech Health plc | -1.6 Million USD | 5744.479% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 9136.93% |
| IXICO plc | 3.27 Million USD | -2667.003% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 13137.608% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 5151.982% |
| CSL Limited | 7.7 Billion USD | 98.826% |
| Cellectis S.A. | 18 Thousand USD | -502572.222% |